Skip to content

Clinical trials

Observational Disruptive, Impulse Control, and Conduct Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disruptive, Impulse Control, and Conduct Disorders Phase: Observational Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20162
20171
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Assistance Publique - Hôpitaux de Paris1
Insel Gruppe AG, University Hospital Bern1
King's College London1
NYU Langone Health1
Public Research Centre Health, Luxembourg1
The University of Hong Kong1
University Hospital, Montpellier1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disruptive, Impulse Control, and Conduct Disorders10
Parkinson Disease5
Anxiety Disorders3
Lethargy2
Mental Disorders2
Psychotic Disorders2
Substance-Related Disorders2
Alcoholism1
Antisocial Personality Disorder1
Bipolar Disorder1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.